Vascular Surgery Products

A line of products designed to provide a gentle approach to the treatment of vascular inflammation and infections, for care, topical and systemic treatment of ‘Circulatory and microcirculatory failure, venous stasis, edema, of Ulcers and of Diabetic Foot

All products of this line are constituted by an association of active ingredients, and optimal dosages to ensure a rapid therapeutic effect.

RSS Journal of Vascular Surgery

  • The case for expanding abdominal aortic aneurysm screening December 9, 2019
    Both the U.S. Preventive Services Task Force and the UK National Institute for Health and Care Excellence are re-evaluating their screening paradigms for abdominal aortic aneurysms (AAAs). Currently, most countries that screen for AAA do so only in male ever-smokers between the ages of 65 and 75 years and in patients with a family history of […]
    Thomas F.X. O'Donnell, Bruce E. Landon, Marc L. Schermerhorn
  • Cross-clamp location affects short-term survival in patients undergoing open abdominal aortic aneurysm repair December 9, 2019
    Open abdominal aortic aneurysm (oAAA) repair in the era of advanced endovascular aortic techniques is used in challenging anatomy. The impact of the location of the proximal aortic cross-clamp (suprarenal [SR] vs infrarenal [IR]) on outcomes remains to be determined. The aim of this study was to analyze the effect of proximal aortic cross-clamp location […]
    Allan M. Conway, Khalil Qato, Nhan T. Nguyen Tran, Guillaume J. Stoffels, Gary Giangola, Alfio Carroccio
  • Aberrant subclavian artery division and revascularization by a supraclavicular approach for definitive or staged treatment of dysphagia lusoria December 9, 2019
    There is no consensus on the optimal approach to treatment of dysphagia lusoria (DL), especially in the absence of a Kommerell diverticulum (KD). We leveraged our institutional experience to clarify the safety and efficacy of aberrant subclavian artery (aSA) division with revascularization by a supraclavicular approach alone in patients with DL.
    Bryan V. Dieffenbach, Gaurav Sharma, Samir K. Shah, Matthew T. Menard, Michael Belkin
  • Accessing the academic influence of vascular surgeons within the National Institutes of Health iCite database December 9, 2019
    A diverse array of measures are used to evaluate academic physicians. One critical factor is the scholarly influence an author has on the research discourse within a field. The National Institutes of Health recently developed the Relative Citation Ratio (RCR) as a method to quantify the influence of published research. The aim of this study […]
    Frank M. Davis, Andrea T. Obi, Katherine A. Gallagher, Peter K. Henke
  • Outcomes after treatment of complex aortic abdominal aneurysms with the fenestrated Anaconda endograft December 9, 2019
    To date, information on the fenestrated Anaconda endograft is limited to case series with a small sample size. This study was performed to assess the technical and clinical outcome of this device in a large international case series.
    Arne de Niet, Clark J. Zeebregts, Michel M.P.J. Reijnen, The Fenestrated Anaconda Study group
  • A systematic review of simulation in open abdominal aortic aneurysm repair December 9, 2019
    Concerns about the long-term durability of endovascular aortic aneurysm repair and the requirement for explantation of stents in the case of infection demonstrate the continued need for open abdominal aortic aneurysm (AAA) repair. However, with the increased complexity and decreasing volume of open cases performed, maintenance of skills and training of younger surgeons are challenging. […]
    Seán C. Maguire, Oscar Traynor, Judith Strawbridge, Adrian O'Callaghan, Dara O. Kavanagh
  • The application of computational modeling for risk prediction in type B aortic dissection December 9, 2019
    New tools are urgently needed to help with surgical decision-making in type B aortic dissection (TBAD) that is uncomplicated at the time of initial presentation. This narrative review aims to answer the clinical question, Can computational modeling be used to predict risk in acute and chronic Stanford TBAD?
    Bijit Munshi, Louis P. Parker, Paul E. Norman, Barry J. Doyle